GHRP vs GHRH: The Two Growth-Hormone Secretagogue Classes Explained (2026)

Growth-hormone secretagogues are among the most-discussed research peptides, and almost all of the confusion around them comes from blurring two different classes: GHRH analogs and GHRPs. They sound similar and both raise growth-hormone signaling, but they act on different receptors through different upstream pathways. Getting the distinction right is essential to reading the literature accurately. This is a research-use explainer, not guidance for human use.

The two classes at a glance

The key fact is the separate receptors. Because the two classes converge on growth-hormone output from different directions, they are mechanistically distinct even though their downstream readout overlaps.

What GHRH analogs do

GHRH — growth-hormone-releasing hormone — is the hypothalamic signal that tells the pituitary to release growth hormone. A GHRH analog is a synthetic molecule designed to mimic that signal at the GHRH receptor. Tesamorelin and CJC-1295 are the analogs that appear most often in research discussion. Because they engage the body's native release pathway, GHRH analogs are studied for producing growth-hormone output that tends to preserve the pulsatile pattern the axis normally uses.

You can review these compounds individually in our peptide reference library, where Tesamorelin and the CJC-1295 / Ipamorelin pairing are documented with their studied mechanisms.

What GHRPs do

GHRPs — growth-hormone-releasing peptides — act on a different receptor: GHS-R1a, the same receptor that the hormone ghrelin binds. Ipamorelin is the cleanest commonly studied example. Rather than mimicking GHRH, GHRPs work through the ghrelin pathway to stimulate and shape growth-hormone release. Because the receptor is different, a GHRP can complement a GHRH analog rather than simply duplicating it.

Why they are studied together

This is the crux. Because GHRH analogs and GHRPs hit two separate receptors, research has repeatedly examined whether combining them produces a complementary effect on the GH axis that neither achieves alone. The most familiar example in the research-peptide world is the pairing of a GHRH analog with a ghrelin-mimetic — the logic being that one supplies the release signal while the other amplifies and modulates the resulting pulse. Our research stacks overview documents how a growth-hormone-axis combination like this is structured in study designs.

The important caveat: "studied together" describes how the literature investigates these compounds. It is not an endorsement of any particular combination for any purpose.

Reading the literature without getting confused

Three habits keep GHRP/GHRH coverage honest:

• Identify the receptor first. If a source can't tell you whether a compound acts on the GHRH receptor or GHS-R1a, treat its claims cautiously.
• Don't generalize across the line. A finding about a GHRH analog says nothing about a GHRP, and vice versa — they are different receptor systems.
• Anchor timing to pharmacokinetics. Secretagogue protocols are sensitive to half-life and pulse timing; see peptide half-life and timing for why this matters, and peptide cycling research protocols for how receptor desensitization shapes study design.

Sourcing secretagogues for research

Both classes are sold as research chemicals, and both demand the same verification: a batch-specific Certificate of Analysis with third-party HPLC purity and mass-spec identity confirmation. Several secretagogues are temperature-sensitive once reconstituted, making handling a real concern. Start with our compound buying guides and the 2026 supplier evaluation before sourcing.

Bottom line

GHRH analogs (like Tesamorelin and CJC-1295) act on the GHRH receptor; GHRPs (like Ipamorelin) act on the ghrelin/GHS receptor. They are two distinct secretagogue classes, frequently studied together precisely because their separate receptors let them complement one another in research designs. Get the receptor straight, don't generalize across classes, and verify the compound before relying on any result. For sourcing, see our where-to-buy guides.

For research use only. This content is informational and does not constitute medical or dosing advice. All compounds referenced are for laboratory research use only — not for human consumption.

Disclosure: Peptide Research Review maintains affiliate relationships with some of the suppliers we reference. Affiliate status has no influence on our research framing or our blinded, third-party lab evaluations. Read our editorial policy and methodology.